학술논문
Ropeginterferon alfa-2b versus standard therapy for polycythaemia vera (PROUD-PV and CONTINUATION-PV): a randomised, non-inferiority, phase 3 trial and its extension study
Document Type
Article
Author
Gisslinger, Heinz; Klade, Christoph; Georgiev, Pencho; Krochmalczyk, Dorota; Gercheva-Kyuchukova, Liana; Egyed, Miklos; Rossiev, Viktor; Dulicek, Petr; Illes, Arpad; Pylypenko, Halyna; Sivcheva, Lylia; Mayer, Jiri; Yablokova, Vera; Krejcy, Kurt; Grohmann-Izay, Barbara; Hasselbalch, Hans C; Kralovics, Robert; Kiladjian, Jean-Jacques; Bauer, Franz; Berbec, Nicoleta; Besses Raebel, Carlos; Borbenyi, Zita; Bumbea, Horia; Buxhofer-Ausch, Veronika; Calbecka, Malgorzata; Cayssials-Caylus, Emilie; Cazzola, Mario; Cerna, Olga; Cucuianu, Andrei; Dima, Delia Monica; Forjan, Ernst; Gheorghita, Emanuil; Greil, Richard; Hatalova, Antonia; Hrubisko, Mikulas; Jakucs, Janos; Kaplan, Polina; Klymenko, Sergiy; Koschmieder, Steffen; Lazaroiu, Mihaela; Lysa, Tamila; Masliak, Zvenyslava; Masszi, Tamas; Mihaylov, Georgi; Myasnikov, Alexander; Platzbecker, Uwe; Puyade, Mathieu; Rey, Jerome; Roy, Lydia; Schwarz, Jiri; Skotnicki, Aleksander; Sokolova, Irina; Soroka-Wojtaszko, Maria; Starzak-Gwozdz, Jolanta; Stoeva, Vera; Torregrosa-Diaz, Jose Miguel; Vallova, Anna; Volodicheva, Elena; Warzocha, Krzysztof; Willenbacher, Ella; Wolf, Dominik
Source
The Lancet Haematology; March 2020, Vol. 7 Issue: 3 pe196-e208, 13p
Subject
Language
ISSN
23523026
Abstract
The PROUD-PV and CONTINUATION-PV trials aimed to compare the novel monopegylated interferon ropeginterferon alfa-2b with hydroxyurea, the standard therapy for patients with polycythaemia vera, over 3 years of treatment.